CATHETER THROMBOSIS side effect
What is CATHETER THROMBOSIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CATHETER THROMBOSIS and Recently Reported Side Effects
CATHETER THROMBOSIS and 15 most Active Side Effect polls
CATHETER THROMBOSIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with CATHETER THROMBOSIS
ARIXTRA AVONEX BEVACIZUMAB CAMPATH CAPECITABINE CEREZYME CETUXIMAB CISPLATIN CYCLOPHOSPHAMIDE DACOGEN ELOXATIN EPTIFIBATIDE ETOPOSIDE FLUOROURACIL GEMCITABINE HEPARIN INTEGRILIN LOVENOX MABTHERA MAGNEVIST NATALIZUMAB NOVOSEVEN REBIF SORAFENIB TARCEVA TYSABRI XELODA ZEVALINHeparin Side Effects Report #5655680-X
Pharmacist from UNITED STATES reported HEPARIN problem on Feb 29, 2008. Male patient, 50 years of age, weighting 167.6 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, dyspnoea, feeling hot, flushing, headache, muscle spasms, ocular hyperaemia, . HEPARIN dosage: unknown. Patient recovered.
Novoseven Side Effects Report #5656760-5
NOVOSEVEN problem was reported by a Physician from AUSTRALIA on Mar 05, 2008. Male patient, weighting 5.84 lb, was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, multi-organ failure, . NOVOSEVEN dosage: .35 MG, UNK. During the same period patient was treated with BLOOD CELLS, BLOOD CELLS, BLOOD CELLS. Patient was hospitalized. Patient died on 02/04/2008.
Capecitabine Side Effects Report #5571016-7
Physician from JAPAN reported CAPECITABINE problem on Dec 14, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pulmonary embolism, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient recovered.
Capecitabine Side Effects Report #5576274-0
CAPECITABINE problem was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pulmonary embolism, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized and became disabled. Patient recovered.
Integrilin Side Effects Report #5507207-0
Physician from UNITED STATES reported INTEGRILIN problem on Oct 23, 2007. Female patient, 57 years of age, was treated with INTEGRILIN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, myocardial infarction, . INTEGRILIN dosage: unknown. During the same period patient was treated with LOVENOX. Patient recovered.
Capecitabine Side Effects Report #5513033-9
CAPECITABINE problem was reported by a Physician from JAPAN on Nov 02, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pulmonary embolism, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5479056-3
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on Sept 18, 2007. Female patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, infusion site pain, swelling, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient recovered.
Avonex Side Effects Report #5484251-3
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, poor venous access, urinary tract infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #5444225-5
Health Professional from UNITED STATES reported GEMCITABINE problem on Sept 04, 2007. Female patient, weighting 340.0 lb, was diagnosed with non-small cell lung cancer and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, jugular vein thrombosis, local swelling, . GEMCITABINE dosage: unknown. During the same period patient was treated with CARBOPLATIN, VELCADE. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5447643-4
CAPECITABINE problem was reported by a Physician from JAPAN on Aug 30, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pulmonary embolism, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Novoseven Side Effects Report #5466523-1
Physician from AUSTRIA reported NOVOSEVEN problem on Sept 17, 2007. Male patient, 17 years of age, weighting 165.3 lb, was diagnosed with haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, . NOVOSEVEN dosage: 7.2 MG, (2 HOURS BETWEEN DOSES). Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5418287-5
CAPECITABINE problem was reported by a Physician from JAPAN on Aug 07, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pneumonia, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5419543-7
Physician from JAPAN reported CAPECITABINE problem on Aug 07, 2007. Male patient, 26 years of age, weighting 161.8 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, pneumonia, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Arixtra Side Effects Report #5758598-7
ARIXTRA problem was reported by a Consumer or non-health professional from FRANCE on May 26, 2008. Female patient, 48 years of age, was diagnosed with thrombosis prophylaxis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, post procedural haemorrhage, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with MEPRONIZINE, DEPAMIDE, EFFEXOR, STABLON, TRIMEPRAZINE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 04/22/2008.
Arixtra Side Effects Report #5776925-1
Consumer or non-health professional from FRANCE reported ARIXTRA problem on June 09, 2008. Female patient, 48 years of age, weighting 251.3 lb, was diagnosed with thrombosis prophylaxis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, post procedural haemorrhage, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with MEPRONIZINE, DEPAMIDE, EFFEXOR, STABLON, THERALENE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 04/22/2008.
Sorafenib Side Effects Report #5793741-5
SORAFENIB problem was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2008. Male patient was diagnosed with prostate cancer metastatic and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, exfoliative rash, fatigue, hyperkalaemia, infection, nausea, pharyngolaryngeal pain, thrombocytopenia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.
Fluorouracil Side Effects Report #5731391-7
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on May 06, 2008. Male patient, weighting 202.2 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, deep vein thrombosis, lung neoplasm, pulmonary embolism, respiratory moniliasis, . FLUOROURACIL dosage: 5684 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5755322-9
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 29, 2008. Female patient, weighting 182.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, deep vein thrombosis, neck pain, . ETOPOSIDE dosage: 220 MG Q8H IV. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5704426-5
Consumer or non-health professional from UNITED STATES reported CETUXIMAB problem on Apr 11, 2008. Female patient, 56 years of age, weighting 149.9 lb, was diagnosed with colon cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, hypotension, pulmonary embolism, treatment failure, urinary tract infection, urosepsis, . CETUXIMAB dosage: 250 MG/M2, WEEKLY, IV. During the same period patient was treated with IRINOTECAN, ATIVAN, CLINDAMYCIN, COMPAZINE, DECADRON, IMODIUM, LISINOPRIL. Patient was hospitalized. Patient recovered.
Cerezyme Side Effects Report #5712098-9
CEREZYME problem was reported by a Physician from NEW ZEALAND on Apr 09, 2008. Female patient, 50 years of age, was diagnosed with gaucher's disease, jugular vein thrombosis and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, flushing, jugular vein thrombosis, superior vena caval occlusion, swelling face, . CEREZYME dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized and became disabled. Patient recovered.
Eloxatin Side Effects Report #5368368-X
Consumer or non-health professional from UNITED STATES reported ELOXATIN problem on June 22, 2007. Male patient, weighting 264.6 lb, was treated with ELOXATIN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, . ELOXATIN dosage: unknown. Patient recovered.
Cisplatin Side Effects Report #5328776-X
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Male patient, weighting 185.2 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, deep vein thrombosis, dilatation ventricular, embolism, myocardial infarction, pelvic venous thrombosis, peripheral ischaemia, pulmonary embolism, . CISPLATIN dosage: 167 MG. Patient was hospitalized. Patient recovered.
Dacogen Side Effects Report #5592820-5
Consumer or non-health professional from UNITED STATES reported DACOGEN problem on Jan 02, 2008. Male patient was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: catheter related infection, catheter thrombosis, staphylococcal infection, . DACOGEN dosage: unknown. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5520680-7
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2007. Male patient, weighting 157.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, catheter thrombosis, frequent bowel movements, inflammation, pancytopenia, pyrexia, . CYCLOPHOSPHAMIDE dosage: 1380 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, AVODART, COREG CR, DARVON. Patient was hospitalized. Patient recovered.
Eptifibatide Side Effects Report #5528753-X
Health Professional from UNITED STATES reported EPTIFIBATIDE problem on Nov 19, 2007. Female patient, 61 years of age, weighting 160.0 lb, was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, catheter thrombosis, coronary artery thrombosis, procedural complication, . EPTIFIBATIDE dosage: 6.8 ML; ONCE; INBO; 4.3 ML; QH; INDRP; 6.8 ML; ONCE; INBO. During the same period patient was treated with LOVENOX, AMIODARONE, DOPAMINE, CARDENE, VISIPAQUE, PLAVIX. Patient died on 04/11/2007.
Natalizumab Side Effects Report #5482029-8
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: catheter site pain, catheter thrombosis, infusion site swelling, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient recovered.
Lovenox Side Effects Report #5489270-9
Health Professional from UNITED STATES reported LOVENOX problem on June 25, 2007. Female patient, weighting 160.3 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, catheter thrombosis, coronary artery thrombosis, . LOVENOX dosage: unknown. During the same period patient was treated with INTEGRILIN, AMIODARONE, DOPAMINE DRIP, DOPAMINE DRIP, NITROGYLCERIN DRIP. Patient died.
Lovenox Side Effects Report #5492329-3
LOVENOX problem was reported by a Pharmacist from UNITED STATES on Oct 01, 2007. Female patient, 60 years of age, weighting 273.4 lb, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, catheter thrombosis, troponin increased, . LOVENOX dosage: unknown. During the same period patient was treated with INTEGRIN, ZOLOFT, VERAPAMIL, TOPROL, DITROPAN, PROTONIX. Patient died on 07/26/2007.
Magnevist Side Effects Report #5420109-3
Physician from GERMANY reported MAGNEVIST problem on Aug 17, 2007. Male patient, 75 years of age, weighting 132.3 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: asthenia, catheter thrombosis, nephrogenic systemic fibrosis, scleroderma, staphylococcal sepsis, urinary tract infection, . MAGNEVIST dosage: unknown. During the same period patient was treated with NORVASC, CLONIDINE, MOXONIDINE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Lovenox Side Effects Report #5420725-9
LOVENOX problem was reported by a Pharmacist from UNITED STATES on Aug 10, 2007. Female patient, 60 years of age, weighting 273.4 lb, was diagnosed with percutaneous coronary intervention and was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, catheter thrombosis, troponin increased, . LOVENOX dosage: unknown. During the same period patient was treated with INTEGRIN, ZOLOFT, VERAPAMIL, TOPROL, DITROPAN, PROTONIX. Patient died on 07/26/2007.
Magnevist Side Effects Report #5381121-6
Physician from GERMANY reported MAGNEVIST problem on June 29, 2007. Male patient, 75 years of age, weighting 132.3 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: asthenia, catheter thrombosis, nephrogenic systemic fibrosis, scleroderma, staphylococcal sepsis, urinary tract infection, . MAGNEVIST dosage: unknown. During the same period patient was treated with NORVASC, CLONIDINE, MOXONIDINE. Patient was hospitalized. Patient recovered.
Eptifibatide Side Effects Report #5382763-4
EPTIFIBATIDE problem was reported by a Health Professional from UNITED STATES on June 28, 2007. Female patient, 61 years of age, weighting 160.0 lb, was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, catheter thrombosis, coronary artery thrombosis, procedural complication, . EPTIFIBATIDE dosage: unknown. During the same period patient was treated with LOVENOX, AMIODORONE, DOPAMINE, CARDENT, VISIPAQUE, PLAVIX. Patient died on 04/11/2007.
Rebif Side Effects Report #5383753-8
Consumer or non-health professional from UNITED STATES reported REBIF problem on June 25, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: balance disorder, catheter thrombosis, depression, economic problem, localised infection, . REBIF dosage: unknown. During the same period patient was treated with PROZAC, STEROIDS. Patient was hospitalized. Patient recovered.
Magnevist Side Effects Report #5381121-6
MAGNEVIST problem was reported by a Physician from GERMANY on June 29, 2007. Male patient, 75 years of age, weighting 132.3 lb, was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: asthenia, catheter thrombosis, nephrogenic systemic fibrosis, scleroderma, staphylococcal sepsis, urinary tract infection, . MAGNEVIST dosage: unknown. During the same period patient was treated with NORVASC, CLONIDINE, MOXONIDINE. Patient was hospitalized. Patient recovered.
Eptifibatide Side Effects Report #5382763-4
Health Professional from UNITED STATES reported EPTIFIBATIDE problem on June 28, 2007. Female patient, 61 years of age, weighting 160.0 lb, was treated with EPTIFIBATIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, catheter thrombosis, coronary artery thrombosis, procedural complication, . EPTIFIBATIDE dosage: unknown. During the same period patient was treated with LOVENOX, AMIODORONE, DOPAMINE, CARDENT, VISIPAQUE, PLAVIX. Patient died on 04/11/2007.
Rebif Side Effects Report #5383753-8
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: balance disorder, catheter thrombosis, depression, economic problem, localised infection, . REBIF dosage: unknown. During the same period patient was treated with PROZAC, STEROIDS. Patient was hospitalized. Patient recovered.
Lovenox Side Effects Report #5727422-0
Consumer or non-health professional from UNITED STATES reported LOVENOX problem on Apr 28, 2008. Female patient was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: adverse event, catheter thrombosis, coronary artery stenosis, . LOVENOX dosage: unknown. Patient recovered.
Tysabri Side Effects Report #5738475-8
TYSABRI problem was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: asthma, catheter thrombosis, condition aggravated, deep vein thrombosis, hypersensitivity, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with COLACE, CYMBALTA, EFFEXOR, FOSAMAX, NEURONTIN, BACLOFEN, AMANTADINE, VITAMIN E. Patient recovered.
Zevalin Side Effects Report #5742466-0
Consumer or non-health professional from GERMANY reported ZEVALIN problem on May 01, 2008. Male patient, 74 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis coronary artery, catheter thrombosis, coronary artery stenosis, febrile neutropenia, myocardial infarction, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5754672-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from JAPAN on May 16, 2008. Male patient was diagnosed with colon cancer, metastases to liver and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, catheter thrombosis, gastrointestinal haemorrhage, lung disorder, neuropathy peripheral, pneumonia, venous thrombosis, . BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with HEPARIN, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, IRINOTECAN. Patient died on 05/13/2008.
Mabthera Side Effects Report #5754796-7
Physician from UNITED KINGDOM reported MABTHERA problem on May 19, 2008. Male patient, 67 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, catheter thrombosis, staphylococcal infection, . MABTHERA dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with PREDNISONE. Patient recovered.
Tarceva Side Effects Report #5330200-8
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood urine present, catheter thrombosis, infection, . TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with ZOCOR, NEXIUM, ZOLOFT, CALCIUM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5311634-4
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 26, 2007. Female patient, weighting 159.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: catheter related complication, catheter thrombosis, deep vein thrombosis, . CYCLOPHOSPHAMIDE dosage: 3268 MG. During the same period patient was treated with CYTARABINE, MERCAPTOPURINE, METHOTREXATE. Patient recovered.
Campath Side Effects Report #5578919-8
CAMPATH problem was reported by a Physician from UNITED STATES on Dec 21, 2007. Female patient, 65 years of age, weighting 97.00 lb, was diagnosed with antifungal prophylaxis and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acidosis, anaemia, catheter thrombosis, cerebral toxoplasmosis, chondrocalcinosis pyrophosphate, escherichia infection, febrile neutropenia, gingival bleeding, headache, . CAMPATH dosage: unknown. During the same period patient was treated with ETOPOSIDE, ONCOVIN, HYDROXYDAUNORUBICIN, CYCLOPHOSPHAMIDE, PREDNISONE, NEUPOGEN, PENTAMIDINE ISETHIONATE, ACYCLOVIR. Patient was hospitalized. Patient died on 05/10/2007.
Xeloda Side Effects Report #5607384-7
Health Professional from UNITED STATES reported XELODA problem on Jan 28, 2008. Male patient, weighting 281.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, catheter sepsis, catheter thrombosis, central line infection, chills, chronic obstructive pulmonary disease, cyanosis, dyspnoea, . XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN, ERBITUX. Patient was hospitalized. Patient recovered.